Overexpression of cathepsin K and vascular endothelial growth factor in chronic venous ulcerations.

INTRODUCTION

Chronic venous disease (CVD) is a disabling condition affecting about 1% to 3% of the general population. Besides varicose veins, CVD can result also in the formation of severe skin lesions, especially venous ulcerations (VU). The exact mechanism of VU is still unknown.

AIM

To evaluate immunoexpression of vascular endothelial growth factor (VEGF) and cathepsin K in healthy individuals and patients with VU.

MATERIAL AND METHODS

The study included 12 patients with venous ulcers and 10 healthy individuals who served as controls; both groups were sex- and age-matched. Biopsy samples were obtained from lower leg areas and submitted to histochemical analysis.

RESULTS

There was a significant difference between the study group and the control group in cathepsin K expression (1.007 ±0.3 vs. 0.22 ±0.2, respectively, < 0.001) and VEGF expression (1.17 ±0.59 vs. 0.27 ±0.19, respectively, < 0.001). Additionally, the microvessel density (per mm) differed significantly between the study group and the control group (97.6 ±28.81 vs. 59.32 ±12.71, respectively, < 0.001). We found no correlation between cathepsin K and microvessel density, and cathepsin K and VEGF in both groups, but there was a significant correlation between microvessel density and VEGF immunoexpression in the study group ( = 0.82, = 0.002).

CONCLUSIONS

Increased immunoexpression of VEGF and cathepsin K suggests that both of these proteins may play a role in VU development.